LLY

Eli Lilly andB

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

LLY vs peer average

70/100

LLY vs. peer average (B vs. C)

Grade spread

B 2 · C 3 · D 2 · F 1

Graded peers loaded

Coverage

8 graded

100% of tracked

Peer overview

AMGN is the first available peer comparator.

Amgen is a useful operating peer because it combines large-cap biotech cash generation with obesity-pipeline exposure, making it relevant for judging how much Lilly's cardiometabolic optionality deserves versus established earnings power.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerAMGNAmgen

LLY

Eli Lilly and

AMGN

Amgen

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Constructive

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs AMGN

LLY / AMGN

Grade Position

Above peers

LLY vs. peer average (B vs. C)

70/100

Momentum

LLY

Value

AMGN

Sentiment

LLY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs LLY

AMGN

40/100

MRK

60/100

ABBV

80/100

Even

JNJ

Johnson & Johnson Common

60/100

NVS

Novartis AG ADR

40/100

AMGN is the first peer returned for this comparison set.